BILL ANALYSIS
HR8297
BULLISHDistrict of Columbia Firearm Freedom Act
HR8297 (District of Columbia Firearm Freedom Act) carries an AI-assessed market impact score of 4/10 with a bullish outlook for investors. This legislation directly affects $SWBI and $RGR. The primary sectors impacted are Manufacturing and Consumer. View the full bill text on Congress.gov.
4/10
Impact Score
bullish
Market Sentiment
2
Affected Stocks
2
Sectors Impacted
Key Takeaways for Investors
HR8297 is an early-stage bill with no hearings, no markup, and no appropriations — it is not a market catalyst.
The bill would deregulate D.C.'s firearms market by removing feature-based bans and registration requirements, benefiting pure-play manufacturers SWBI and RGR but at a de minimis revenue level.
Real market data shows SWBI and RGR trading near 52-week highs with 7-9% gains over the past 30 days, but this bill alone does not explain those moves.
How HR8297 Affects the Market
The market impact of HR8297 at this stage is effectively zero. SWBI at $15.58 and RGR at $43.60 are trading near their 52-week highs, with both stocks posting 7-9% gains over the past 30 days. However, those moves are better attributed to broader sector trends and Supreme Court signals than to this single procedural bill. Investors should treat this as a non-event until the bill advances past committee — which is highly unlikely in the current Congress.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR8297 |
| Impact Score | 4/10Certainty: Committee hearing · Financial Magnitude: $550M — substantial funding · Strategic Weight: AI qualitative assessment: 1/10 · Market Penetration: 2 companies directly affected across 2 sectors |
| Market Sentiment | bullish |
| Event Date | |
| Affected Sectors | Manufacturing, Consumer |
| Affected Stocks | $SWBI, $RGR |
| Source | View on Congress.gov → |
Summary
HR8297 is a bill introduced April 15, 2026, that would remove D.C.'s feature-based firearm bans, registration requirements, and concealed carry restrictions. It is in the earliest procedural stage — referred to two committees — with zero appropriations. The bill is not a market-moving catalyst at this stage. Pure-play firearm manufacturers SWBI and RGR would benefit structurally if enacted, but D.C. represents a negligible share of the U.S. firearms market.